Results 191 to 200 of about 2,033,503 (343)

Characterizing the salivary RNA landscape to identify potential diagnostic, prognostic, and follow‐up biomarkers for breast cancer

open access: yesMolecular Oncology, EarlyView.
This study explores salivary RNA for breast cancer (BC) diagnosis, prognosis, and follow‐up. High‐throughput RNA sequencing identified distinct salivary RNA signatures, including novel transcripts, that differentiate BC from healthy controls, characterize histological and molecular subtypes, and indicate lymph node involvement.
Nicholas Rajan   +9 more
wiley   +1 more source

Correction: Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy. [PDF]

open access: yesMol Cancer
Iida M   +9 more
europepmc   +1 more source

BRAND VALUATION VERSUS BRAND EVALUATION [PDF]

open access: yes, 2014
Lypka, M., Pilova, Kateryna, Shvets, O.
core  

Generic Advertising in Concentrated and Differentiated Agricultural Markets [PDF]

open access: yes
This study develops an analytical framework to examine the impact of generic advertising on brand advertising with alternative assumptions on demand changes (shift-up and rotation), product differentiation, market concentration, and relationship between ...
Chung, Chanjin   +2 more
core   +1 more source

Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology

open access: yesMolecular Oncology, EarlyView.
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy